With the analysis among 4,472 patents, we discovered top 428 key players by total patent application. Genzyme Corp., Janssen Vaccines & Prevention BV, Janssen Sciences Ireland Unlimited Co. are dominant in this area. They take 9.01% of the total patent filing.
Massachusetts, United States
Patent: 147
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 104
Janssen Sciences Ireland Unlimited Co.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 88
F. Hoffmann-La Roche Ltd.
4D Molecular Therapeutics, Inc.
California, United States
Patent: 84
Massachusetts, United States
Patent: 77
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Adverum Biotechnologies, Inc.
California, United States
Patent: 60
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 55
With the analysis among 273 patents, we discovered top 26 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Stridebio, Inc., Valo Therapeutics Oy are active in this area.
Institut National de la Santé et de la Recherche Médicale
North Carolina, United States
Patent: 36
Kansas, United States
Patent: 19
Pennsylvania, United States
Patent: 19
LogicBio Therapeutics, Inc.
California, United States
Patent: 12
Basel-Stadt, Switzerland
Patent: 10
PackGene Biotech Co., Ltd.
Guangdong Sheng, China
Patent: 9
Huida (Shanghai) Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 8
With the analysis among related 3,306 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing TRUSTEES OF THE UNIV OF PENNSYLVANIA, The University of North Carolina at Chapel Hill, Regeneron Pharmaceuticals, Inc. take 17.51% of patent filing during this period.
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 395
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 96
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 88
Janssen Sciences Ireland Unlimited Co.
Massachusetts, United States
Patent: 77
Institut National de la Santé et de la Recherche Médicale
4D Molecular Therapeutics, Inc.
California, United States
Patent: 68
Regents of the University of California
California, United States
Patent: 66
California, United States
Patent: 47
With the analysis among related 3,306 patents in last 5 years, we discover 331 new entrants. Regeneron Pharmaceuticals, Inc., Generation Bio Co., Stridebio, Inc. are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 88
Massachusetts, United States
Patent: 77
North Carolina, United States
Patent: 36
Sangamo Therapeutics, Inc.
California, United States
Patent: 33
Université d'Evry Val d'Essonne
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 27
Bern, Switzerland
Patent: 22
With the analysis among 2,996 patents, we discovered top 247 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, University of Massachusetts, Ruprecht-Karls-Universität Heidelberg are dominant in this area. They take 35.01% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 222
University of Massachusetts
Massachusetts, United States
Patent: 63
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 55
New York, United States
Patent: 46
Université d'Evry Val d'Essonne
The Johns Hopkins University
Consejo Superior de Investigaciones Científicas
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 27
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 26